Coming Soon
Understand the history of acute kidney injury (AKI) with this guide. Explore clinical documentation requirements, AKI diagnosis codes (ICD-10), staging criteria, and common causes like acute tubular necrosis (ATN). Learn about pre-renal AKI, intrinsic AKI, and post-renal AKI, along with relevant lab values such as serum creatinine and blood urea nitrogen (BUN). This resource provides insights for healthcare professionals, medical coders, and clinicians seeking information on documenting and coding AKI accurately.
Also known as
Acute kidney failure and chronic
Covers acute kidney injury and related chronic conditions.
Personal history of kidney disease
Indicates a past episode of kidney disease, including acute injury.
Hypertensive chronic kidney disease
May be relevant if hypertension contributed to past acute injury.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the AKI currently acute?
When to use each related code
| Description |
|---|
| Acute Kidney Injury |
| Prerenal Azotemia |
| Acute Tubular Necrosis (ATN) |
Coding AKI without staging (stage 1-5) or specifying cause (prerenal, intrinsic, postrenal) leads to inaccurate severity and reimbursement.
Incorrectly coding CKD and AKI concurrently when AKI is a CKD exacerbation can inflate comorbidity and case mix index.
Missing documentation of AKI diagnostic criteria (creatinine, urine output) makes coding validation difficult and increases audit risk.
Q: What are the most common pre-renal causes of acute kidney injury in hospitalized patients, and how can I quickly differentiate them?
A: Pre-renal acute kidney injury (AKI), stemming from reduced renal perfusion, is the most frequent cause of AKI in hospitalized patients. Common pre-renal causes include hypovolemia (from hemorrhage, dehydration, or excessive diuresis), decreased cardiac output (due to heart failure, cardiogenic shock, or pulmonary embolism), and systemic vasodilation (seen in sepsis or anaphylaxis). Rapid differentiation involves assessing volume status (e.g., orthostatic hypotension, jugular venous pressure), cardiac function (e.g., echocardiography, BNP levels), and systemic circulation (e.g., mean arterial pressure, systemic vascular resistance). Prompt recognition and correction of the underlying cause are crucial to prevent intrinsic renal damage. Explore how different fluid management strategies impact AKI outcomes in various clinical scenarios.
Q: How can I effectively distinguish between pre-renal AKI and acute tubular necrosis (ATN) using clinical and laboratory findings, especially when the presentation is ambiguous?
A: Differentiating pre-renal AKI from ATN, a form of intrinsic AKI, can be challenging, particularly in early stages. While both present with elevated serum creatinine and decreased urine output, some clues can aid differentiation. In pre-renal AKI, fractional excretion of sodium (FeNa) is typically less than 1%, urine osmolality is high (>500 mOsm/kg), and the BUN/creatinine ratio is elevated (>20:1). Conversely, in ATN, FeNa often exceeds 2%, urine osmolality is low (<350 mOsm/kg), and the BUN/creatinine ratio tends to be normal or slightly elevated. However, these indices can be unreliable in certain situations (e.g., diuretic use, chronic kidney disease). Consider implementing a urine microscopy analysis, as muddy brown casts can suggest ATN, while a bland sediment favors pre-renal AKI. Learn more about the role of novel biomarkers in improving the diagnostic accuracy of AKI subtypes.
Patient presents with a history of acute kidney injury (AKI), diagnosed on [date of original diagnosis] based on [criteria used for initial diagnosis; e.g., KDIGO criteria demonstrating a rise in serum creatinine of [value] within [timeframe], or a decrease in urine output to [value] within [timeframe]). The etiology of the initial AKI was determined to be [cause of AKI; e.g., prerenal azotemia secondary to dehydration, acute tubular necrosis due to nephrotoxic medication, post-renal obstruction due to [cause]]. At the time of the original diagnosis, the patient presented with [symptoms; e.g., oliguria, anuria, edema, fatigue, nausea, vomiting, shortness of breath]. Relevant laboratory findings at that time included serum creatinine of [value], BUN of [value], and GFR of [value]. Urinalysis revealed [urinalysis findings; e.g., granular casts, proteinuria, hematuria]. Imaging studies [mention imaging performed, e.g., renal ultrasound, CT abdomen pelvis] showed [imaging findings; e.g., normal kidney size, bilateral hydronephrosis]. The patient was treated with [treatment provided; e.g., intravenous fluids, diuretics, renal replacement therapy]. The patient’s renal function subsequently [improved, stabilized, declined] and reached a baseline creatinine of [value]. Currently, the patient [denies, reports] symptoms consistent with recurrent AKI. Current laboratory values show serum creatinine of [value], BUN of [value], and GFR of [value]. This information is relevant for medical coding and billing using ICD-10 code N61.9, History of acute kidney failure, unspecified, and should inform ongoing monitoring for chronic kidney disease (CKD) and future episodes of acute kidney injury. Further evaluation and management will be based on current clinical presentation and the need to identify and address any modifiable risk factors for recurrent AKI and the development of CKD.